Tag Archives: takes

Pfizer, Merck KGaA's Bavencio takes a hit with second ovarian cancer failure

Back in November, Pfizer and Merck KGaA reported that immuno-oncology drug Bavencio had failed a late-stage ovarian cancer trial. And now the companies can make it two. Friday, the partners said they’d scrapped a phase 3 study examining Bavencio in combination with and/or after chemo in previously untreated patients after the drug showed it couldn’t… Read More »

Shoppers takes page from Big Pharma, sponsors talks for doctors on medical cannabis, which it plans to sell

The pharmaceutical industry has done it for years, officially to educate doctors, unofficially to convince them to prescribe more of their medicines. Now the practice of company-sponsored seminars by specialists known in the drug business as “key opinion leaders” — and criticized as salespeople in disguise – has come to the burgeoning world of medical… Read More »

  1. Pages:
  3. 1
  4. 2
  5. 3